These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25170162)

  • 21. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women.
    Huppert JS; Mortensen JE; Reed JL; Kahn JA; Rich KD; Miller WC; Hobbs MM
    Clin Infect Dis; 2007 Jul; 45(2):194-8. PubMed ID: 17578778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loop mediated isothermal amplification assay for detection of Trichomonas vaginalis in vaginal swabs among symptomatic women from North India.
    Khurana S; Dadwal R; Sharma N; Mewara A; Singh S; Bagga R; Yadav R; Sethi S
    Lett Appl Microbiol; 2020 Mar; 70(3):196-202. PubMed ID: 31808556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases.
    Saxena SB; Jenkins RR
    Sex Transm Dis; 1991; 18(3):138-42. PubMed ID: 1948509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
    Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
    Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection.
    Munson E; Kramme T; Napierala M; Munson KL; Miller C; Hryciuk JE
    J Clin Microbiol; 2012 Dec; 50(12):3927-31. PubMed ID: 23015673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.
    Schwebke JR; Hobbs MM; Taylor SN; Sena AC; Catania MG; Weinbaum BS; Johnson AD; Getman DK; Gaydos CA
    J Clin Microbiol; 2011 Dec; 49(12):4106-11. PubMed ID: 21940475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.
    Hardick A; Hardick J; Wood BJ; Gaydos C
    J Clin Microbiol; 2006 Nov; 44(11):4197-9. PubMed ID: 16943353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Molecular Screening in a Cohort of Young Men Who Have Sex With Men and Transgender Women: Effect of Additive Rectal Specimen Source Collection and Analyte Testing.
    Munson E; Reynoso A; Pass M; Buehler K; Ryan D; Clifford A; Morgan E; Mustanski B
    Sex Transm Dis; 2020 Nov; 47(11):748-753. PubMed ID: 33045163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis.
    Webb B; Crampton A; Francis MJ; Hamblin J; Korman TM; Graham M
    Pathology; 2021 Feb; 53(2):257-263. PubMed ID: 33036769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.
    Ginocchio CC; Chapin K; Smith JS; Aslanzadeh J; Snook J; Hill CS; Gaydos CA
    J Clin Microbiol; 2012 Aug; 50(8):2601-8. PubMed ID: 22622447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients.
    Muzny CA; Tamhane AR; Eaton EF; Hudak K; Burkholder GA; Schwebke JR
    Int J STD AIDS; 2019 Mar; 30(4):344-352. PubMed ID: 30486764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis.
    Dize L; Agreda P; Quinn N; Barnes MR; Hsieh YH; Gaydos CA
    Sex Transm Infect; 2013 Jun; 89(4):305-7. PubMed ID: 23093735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.
    Muzny CA; Burkholder GA; Fry KR; Austin EL; Schwebke JR
    Sex Transm Dis; 2016 Aug; 43(8):483-8. PubMed ID: 27419815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.
    Gaydos CA; Schwebke J; Dombrowski J; Marrazzo J; Coleman J; Silver B; Barnes M; Crane L; Fine P
    Expert Rev Mol Diagn; 2017 Mar; 17(3):303-306. PubMed ID: 28092466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictors of trichomonas infection in newly incarcerated women.
    Nijhawan AE; Chapin KC; Salloway R; Andrea S; Champion J; Roberts M; Clarke JG
    Sex Transm Dis; 2012 Dec; 39(12):973-8. PubMed ID: 23191953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.
    Boiko I; Golparian D; Krynytska I; Unemo M
    APMIS; 2019 Sep; 127(9):627-634. PubMed ID: 31225920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic.
    Joyner JL; Douglas JM; Ragsdale S; Foster M; Judson FN
    Sex Transm Dis; 2000 Apr; 27(4):236-40. PubMed ID: 10782747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding cases of Trichomonas vaginalis infection in England.
    Mahto M; Evans-Jones J; Zia S; Robinson TI; Rothburn MM; Mallinson H
    Int J STD AIDS; 2011 Aug; 22(8):471-3. PubMed ID: 21795421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and morbidity of urethral Trichomonas vaginalis in Japanese men with or without urethritis.
    Seike K; Maeda S; Kubota Y; Tamaki M; Yasuda M; Deguchi T
    Sex Transm Infect; 2013 Sep; 89(6):528-30. PubMed ID: 23349337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.